Related Experiment Video
Updated: Aug 12, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Seroprevalence of HIV-2 infection in Greece (Crete)
V Georgoulias1, A Agelakis, P Fountouli
1AIDS Reference Center of Crete, Venizelion Hospital, Greece.
Insights
This study evaluated Human Immunodeficiency Virus type 2 (HIV-2) seroprevalence in blood donors and individuals seeking HIV testing. Confirmed HIV-2 infections were rare, with most repeatedly positive results being indeterminate or negative upon further testing.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Human Immunodeficiency Virus type 2 (HIV-2) is a distinct viral strain with a different epidemiological profile than HIV type 1 (HIV-1).
- Understanding HIV-2 seroprevalence is crucial for blood safety and public health surveillance, particularly in diverse populations.
Purpose of the Study:
- To determine the seroprevalence of HIV-2 among blood donors and individuals undergoing HIV testing.
- To characterize the reactivity patterns of sera tested for HIV-2 using enzyme immunoassay (EIA) and Western blot.
Main Methods:
- Screening of 20,407 blood donors, 100 homosexual/bisexual individuals, and 7,020 heterosexual individuals using EIA for HIV-2 antibodies.
- Confirmation of repeatedly positive sera using Western blot analysis.
- Further characterization of antibody reactivity using synthetic peptides homologous to HIV-2 gp36 and gp41 antigens.
Main Results:
- Sixty-seven sera showed repeated positivity for HIV-2 antibodies.
- Western blot analysis confirmed HIV-2 infection in only four cases.
- Twenty-five sera exhibited indeterminate patterns, and 38 were negative; none cross-reacted with HIV-1 antigens.
Conclusions:
- The seroprevalence of confirmed HIV-2 infection is low in the studied populations.
- Indeterminate Western blot results are common in HIV-2 testing and require careful interpretation.
- Further investigation into the specific peptide reactivity can aid in understanding immune responses to HIV-2.
Abstract:
The seroprevalence of HIV-2 was evaluated in 20,407 consecutive normal blood donors, 100 homo- and/or bisexuals, and 7,020 heterosexuals presenting for an HIV test using an EIA test. Sixty-seven sera were revealed to be repeatedly positive. Analysis by Western blot confirmed the infection in four cases, an indeterminate (antibodies against only the gag-encoded proteins) pattern was revealed in 25 cases, whereas 38 sera were negative. Three of the four HIV-2-positive sera also reacted with two distinct, but close, synthetic peptides homologous to viral gp36. The fourth serum, which did not display antibodies against gp36 on Western blot, did not react with gp36-derived synthetic peptides. None of these sera reacted with native HIV-1 antigens or synthetic peptides homologous to gp41. Sera with an indeterminate HIV-2 Western blot did not react with gp36-derived synthetic peptides. Although 10 of them also displayed an indeterminate HIV-1 Western blot, no serum sample reacted with two gp41-derived synthetic peptides or proved to be positive when they tested for p24 antigen. One bisexual and one heterosexual HIV-2 positive subject reported sexual contacts with West Africans, whereas two other heterosexuals had had multiple sexual partners from different countries.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Infectious Diseases and Their Occurrence
Genital Herpes
Toxoplasmosis
Viral Hepatitis I: Introduction

